Influenza vaccine
US10925958B2 · kind B2 · utility
59Cited by
35References
24Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Nov 10, 2017 |
| Grant date | Feb 23, 2021 |
| Priority date | — |
| Expiry date | Nov 10, 2037 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2760/16134
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to compositions and methods for the preparation, manufacture and therapeutic use ribonucleic acid vaccines comprising polynucleotide molecules encoding one or more influenza antigens, such as hemagglutinin antigens.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.